Healthcare Economics & Policy

After several months of buildup, the CMS Hospital Compare website began to offer overall hospital star ratings July 27. According to the agency, the system is meant to offer patients a way to quickly and uniformly compare potential hospitals.

The Centers for Medicare & Medicaid Services (CMS) announced on July 25 a five-year proposed bundled payments model for hospitals that treat Medicare patients following an MI or bypass surgery. CMS also announced a proposed five-year cardiac rehabilitation incentive payment model to encourage hospitals to refer patients to cardiac rehabilitation.

Medtronic agreed to acquire HeartWare International Inc. on June 27 for approximately $1.1 billion.

Valeant Pharmaceuticals announced on May 16 that it would reduce the price of two heart drugs by as much as 40 percent. The program will decrease the price of Nitropress and Isuprel, two of Valeant’s medications. 

Abbott Laboratories is set to acquire St. Jude Medical in a cash and stock transaction valued at approximately $25 billion.

A microsimulation cardiovascular disease risk prediction model found that a 10 percent subsidy on the price of fruits and vegetables would lead to reductions in cardiovascular disease deaths, non-fatal MI and non-fatal stroke. 

Lawyers for patients suing Johnson & Johnson and Bayer allege that the companies misled editors at The New England Journal of Medicine about the safety of rivaroxaban (Xarelto), the New York Times reports. 

During the third quarter of fiscal year 2016, Medtronic’s revenue increased six percent to $6.394 billion, while its diluted earnings per share decreased one percent to $0.77 per share.

For the fourth quarter of 2015, Boston Scientific’s sales hit $1.978 billion, representing a 10 percent jump in operational revenue compared with the same time period the previous year, while its adjusted earnings per share increased from $0.22 to $0.26.

Are you maximizing your reimbursement based on your cardiovascular patient base? How have you been handling all of the new coding updates around ICD-10 since October 1st, along with the scrutiny around increased specificity with medical documentation?

For the fourth quarter of 2015, St. Jude Medical’s revenue in its cardiac rhythm management division declined 10 percent on a constant-currency basis compared with the same time period in 2014. Meanwhile, revenue in its atrial fibrillation, cardiovascular and neuromodulation divisions increased 4 percent, 2 percent and 9 percent, respectively.

A recent study suggests the Watchman may save money and be more cost-effective than novel oral anticoagulants in the long-run.